Gilead Sciences Inc Stock
€98.57
Your prediction
Financial data and news for Gilead Sciences
sharewise wants to provide you with the best news and tools for Gilead Sciences, so we directly link to the best financial data sources.
Financials
News
Gilead Sciences Stock: HIV Drug Prospects Drive Growth
Morgan Stanley's optimistic outlook for Gilead Sciences' HIV prevention medication Lenacapavir has positioned the company for significant market advancement. The drug, anticipated to receive FDA
Gilead Sciences Stock: FDA Fast-Tracks HIV Drug Review
Gilead Sciences experienced a notable uptick in its NASDAQ trading performance, with shares climbing 1.5% to reach $105.60. This movement brings the stock close to its 52-week high of $106.68
Gilead Sciences Stock: Shares Near 52-Week High Amid Growth
Gilead Sciences is experiencing remarkable momentum on the NASDAQ, with its stock currently trading at $105.25, approaching its 52-week peak of $105.37. The biotechnology company has demonstrated
Gilead Sciences Stock: Shares Surge 8% on Stellar Earnings
Gilead Sciences witnessed a remarkable surge in its stock performance on Wednesday, with shares climbing over 8% to reach a new 52-week high of $104.64. The biotechnology company's impressive